Skip to main content
. 2017 Feb 3;8(13):21281–21289. doi: 10.18632/oncotarget.15068

Figure 4. Validation of differential expression of GJB2 and ERO1LB in GSE71729.

Figure 4

A. Elevated expression of GJB2 in pancreatic adenocarcinoma. B. Reduced expression of ERO1LB in pancreatic adenocarcinoma.